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PerspectivesPerspectives on Surgery in the Time of COVID-19: Safety FirstPrimum non nocere: First, do no harm. This is a profes-
sional and ethical imperative with which we as physicians
are very familiar. Can we expand this principle to include
the patient and the healthcare team? As minimally inva-
sive surgeons and ambassadors, the authors could never
have imagined penning a document that argues the merits
of traditional open surgery. We are all ardent supporters of
minimally invasive techniques and the myriad benefits
they afford. However, we now find ourselves in the
midst of a global crisis from the coronavirus disease
2019 (COVID-19) pandemic; a time when the word
“unprecedented” has taken on new meaning. Since early
March, it has been reported that more than 3300 healthcare
workers in China were infected with COVID-19, whereas
in Italy, upward of 20% of healthcare workers have been
infected with news reports of more than 50 deaths among
physicians [1].
Significant and realistic concerns have been raised
regarding the risk of severe acute respiratory syndrome
coronavirus (SARS-CoV)−2 (the virus responsible for
COVID-19 disease) dissemination during minimally inva-
sive surgery owing to pneumoperitoneum-associated aero-
solization of particles and the presence of the virus in blood
and stool [2]. It is important to recognize that our under-
standing of viral aerosolization by electrosurgical or ultra-
sonic tools comes from work with other viral diseases, such
as hepatitis B [3]. Particles in surgical smoke have been
demonstrated to contain a variety of toxic and virulent
materials thought to be potentially capable of infecting
those who inhale them, with case reports of doctors con-
tracting a rare papillomavirus when surgical smoke expo-
sure was suspected to be the source [4]. The plausibility of
aerosol and fomite transmission of SARS-CoV-2 has been
established, with similar findings to that of SARS-CoV-1
(the virus responsible for a multinational disease outbreak
in 2002−2003), which was associated with nosocomial
transmission and superspreading events [5]. There have
been particular concerns raised about laparoscopic surgery
because of the higher concentrations of particulate matter
that occur compared with open surgery, which may be dueThe authors declare that they have no conflict of interest.
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ity of pneumoperitoneum, and gas expulsion through ports
or trocars [4].
Regarding COVID-19 specifically, we emphasize that
there are no data on surgical exposures translating into a
definitive risk to the operating room team. With a dearth of
scientific evidence to guide us, the healthcare community is
left with 2 solutions. The first involves continuing on with
normal practice unless it becomes clear that these practices
are definitively harmful. Proponents of maintaining the sta-
tus quo will no doubt highlight the fact that the scientific
community is too early in our understanding of COVID-19
to have proven a causal link between surgical exposures
and infection of healthcare workers. Surgeons may argue
that there is no evidence specific to laparoscopic plume con-
taining SARS-CoV-2 resulting in infection. The rebuttal to
this stance is that neither is there evidence of safety. The
authors suggest championing an alternative solution
whereby we as a medical community become proactive
rather than reactive, adopting a conservative yet balanced
plan to protect both the patient and the healthcare team.
When faced with a biologically plausible concern that could
infer serious harm, we are obligated to act with an abun-
dance of caution, examining and questioning our standard
practices.
Certainly, it is uncomfortable to consider changing prac-
tice in the absence of definitive evidence, but let us consider
whether it will be possible to obtain such evidence either
now or in the foreseeable future. The necessary studies on
this subject would require lengthy follow-up, be difficult to
conduct, and expose a vast number of staff to potential risk
in the process. Equipoise concerns may preclude such work
taking place in the in vivo setting. Reliable information on
this subject is not likely forthcoming anytime soon, and yet
we are required to act now to alter practice if we wish to
avoid exposure risks. We must bear in mind that the
absence of data is not data in and of itself, or taken another
way, just because surgical exposures have not been proven
to be harmful, does not mean that it is safe to proceed with
usual practice. The reality is that decision making and
guideline development in this arena will be based on the
limited available data and the information inferred from
other viruses and similar epidemics.
Cohen et al. 793Taking the aforementioned discussion into account, we
propose the following management algorithm. In patients
who are COVID-19 positive, unless they have a life-threat-
ening emergency that requires surgery, we advocate for
nonoperative treatment and delay of surgery until recov-
ered. If surgery cannot be delayed for a patient who is
COVID-19 positive, a laparotomic operation should be per-
formed. In patients with unknown COVID-19 status, preop-
erative testing is ideal when available, although it is
important to also consider the test’s sensitivity/specificity
and underlying degree of suspicion on the basis of symp-
toms and local disease prevalence. Laparoscopy can be per-
formed in a patient whose COVID-19 status is unknown if
the entire operating room team has access to necessary per-
sonal protective equipment and extreme care is taken to
prevent release of pneumoperitoneum into the operating
theater. If these measures are not in place, an open opera-
tion is the alternative. The many advantages of laparoscopy
are well-known, and it is important to stress that there will
be cases and patients for whom the risks of a laparotomy
far outweigh the risks of laparoscopy, even when taking
into account utilitarian concerns for the healthcare team
regarding potential exposure issues. Outside of these unique
situations, however, the use of laparoscopy should be
reserved for the patient who is COVID-19 negative; or in
the absence of testing, in patients who are symptom- and
exposure-screened negative with full deployment of per-
sonal protective equipment (Supplemental Fig. 1).
We must also keep an open mind to alternatives to tradi-
tional minimally invasive surgery, which may be appropri-
ate in most cases during this pandemic. With the
suspension of nonessential procedures, many of the emer-
gent benign gynecologic cases that we will be approaching
in patients who are COVID-19 positive or unknown status
(such as ovarian torsion or ectopic pregnancy) could be
accomplished through minilaparotomy with little to no use
of electrosurgery and same day discharge. This approach
could prove to optimize benefits to both the patient and the
healthcare team. In addition, regional anesthesia is feasible
with this technique, which could allow for further limitation
of healthcare team exposures related to the aerosol-generat-
ing procedures of intubation and extubation. Whether oper-
ating using minimally invasive or open techniques,
effective mechanisms exist for the removal of smoke and
particulate matter that can significantly reduce the surgical
team exposure. Whenever possible, electrosurgical/ultra-
sonic device use should be coupled with a smoke evacua-
tion/filtration system.
It is our fervent hope that as more data comes to light,
the arguments made in this piece may no longer beapplicable. With more accurate, rapid, and available testing
for COVID-19, including serum tests of markers of acute
infection and immunity, the decision making will become
more streamlined. In addition, if future evidence demon-
strates a lack of infectivity of the aerosolized, blood, or
fluid-borne viral particles, then the aforementioned discus-
sions may become moot. Until such time, however, let us
not allow blind allegiance to 1 approach be the primary fac-
tor determining surgical route. The best outcomes for all
can be achieved when individual patient and local circum-
stances are considered, along with surgical experience and
judgment.
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